Ultragenyx Pharmaceutical, Inc. (RARE)

22.72 +0.89 (+4.08%) USD  |  NASDAQ  |  Feb 20, 16:00
22.50 -0.22 (-0.97%) After-Hours: 07:21
More

Ultragenyx Pharmaceutical Annual EBITDA Margin Estimates

Annual EBITDA Margin Estimates Chart

View Annual EBITDA Margin Estimates for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EBITDA Margin Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EBITDA Margin Estimates Range, Past 5 Years

View Annual EBITDA Margin Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EBITDA Margin Estimates Benchmarks

View Annual EBITDA Margin Estimates Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
CorMedix, Inc. Upgrade
Insmed, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade